🇺🇸 FDA
Patent

US 12083246

Composite gels and methods of use thereof

granted A61KA61K47/32A61K9/0019

Quick answer

US patent 12083246 (Composite gels and methods of use thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Sep 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K47/32, A61K9/0019, A61K9/06, A61K9/146